MCKMcKesson Corporation

$115B

Q1 2019 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$52.6B+3.0% YoY

Gross Profit

$2.6B5.0% margin

Operating Income

$617M1.2% margin

Net Income

-$138M-0.3% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$1.1B

Free Cash Flow

-$1.2B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$61.3B

Total Liabilities

$50.2B

Stockholders' Equity

$9.4B

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52.6B	$51.1B	+3.0%
Gross Profit	$2.6B	$2.4B	+7.5%
Operating Income	$617M	$605M	+2.0%
Net Income	-$138M	$307M	-145.0%

Revenue Segments

U.S. Pharmaceutical Segment

$41.0B96%

Medical-Surgical Solutions Segment

$1.7B4%

Geographic Segments

UNITED STATES

$42.9B82%

International Segment

$9.7B18%

MCK Q1 2019 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena